Determinants of control of high blood pressure. The Oslo Health Study 2000–2001

References

• Wolf-Maier K, Cooper RS, Banegas JR, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 2003; 289: 2363–9.
   Google Scholar
• Guidelines Committee. 2003 European Society of Hyper-tension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011–53.
   Google Scholar
• Chobanian A, Bakris GL, Black HR, et al. The seventh report of the Joint National committee on prevention, detection, evaluation, and treatment of high blood pressure. The JNC7 report. JAMA 2003; 289: 2560–72.
   PubMed Web of Science ®Google Scholar
• Wolf-Maier K, Cooper RS, Kramer H, et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 2004; 43: 10–17.
   PubMed Web of Science ®Google Scholar
• EUROASPIRE II Study Group. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries. Principal results from EUROASPIRE II Euro Heart Survey program. Eur Heart J 2001; 22: 554–72.
   PubMed Web of Science ®Google Scholar
• Berlowitz DR, Ash AS, Hickey EC, et al. Inadequate management of blood pressure in a hypertensive population. N Engl J Med 1998; 339: 1957–63.
   PubMed Web of Science ®Google Scholar
• O'Connor PJ. Overcome clinical inertia to control systolic blood pressure. Arch Intern Med 2003; 263: 2677–8.
   Google Scholar
• Hetlevik I, Holmen J, Kruger 0, Holen A. Fifteen years with clinical guidelines in the treatment of hypertension - still discrepancies between intentions and practice. Scand J Primary Health Care 1997; 15: 13/1 /10.
   Google Scholar
• Oliveria SA, Lapuerta P, McCarthy BD, Liftalien GJ, Berlowitz DR, Asch SM. Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med 2002; 162: 413–20.
   PubMed Web of Science ®Google Scholar
• Waeber B. Treatment strategy to control blood pressure optimally in hypertensive patients. Blood Press 2001; 10: 62–73.
   PubMed Web of Science ®Google Scholar
• Waeber B, Brunner HR. The multifactorial nature of hyper-tension: the greatest challenge for its treatment? J Hypertens 2001; 19 Suppl 3: 59–16.
   Google Scholar
• Per G. Lund-Larsen: Arven fra Statens skjermbildefotogra-fering (SSF)/Statens helseundersokelser (SHUS): En intro-duksjon til databanken. Nor J Epidemiol 2003; 13: 4–18. Full text available: http://www.medisin.ntnu.no/ism/nofe/ norepid/2003(1)%2004-Innledning.pdf.
   Google Scholar
• Vollset SE. Confidence intervals for a binomial proportion. Stat Med 1993; 12: 808–24.
   Web of Science ®Google Scholar
• Borzecki AM, Wong AT, Hickey EC, Ash AS, Berlowitz DR. Hypertension control. How well are we doing? Arch Intern Med 2003; 163: 2705–11.
   PubMedGoogle Scholar
• Berlowitz DR, Ash AS, Hickey EC, et al. Hypertension management in diabetes: the need for more aggressive therapy. Diabetes Care 2003; 26: 355–9.
   PubMed Web of Science ®Google Scholar
• Tonstad S, Rosvold EO, Furu K, Skurtveit S. Under-treatment and overtreatment with statins: the Oslo Health Study 2000-2001. J Intern Med 2004; 255: 494–502.
   PubMed Web of Science ®Google Scholar
• Kanbay M, Yildirir A, Bozbas H, Ulus T, Demirtas K, Muderrisoglu H. Atorvastatin therapy helps to control blood pressure levels in hypertensive dyslipidemic patients. Atherosclerosis 2004; 5 Suppl 1: 126.
   Web of Science ®Google Scholar
• Schelleman H, Klungel OH, Kromhout D, de Boer A, Sticker BH, Verschuren W. Prevalence and determinants of undertreatment of hypertension in the Netherlands. J Human Hypertens 2004; 18: 317–24.
   PubMed Web of Science ®Google Scholar
• Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med 2001; 345: 479–86.
   PubMed Web of Science ®Google Scholar
• Barker WH, Mullooly JP, Linton KL. Trends in hyper-tension prevalence, treatment, and control in a well-defined older population. Hypertension 1998; 31: 552–9.
   Google Scholar
• Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003; 290: 199–206.
   PubMed Web of Science ®Google Scholar
• De Backer G, Ambrosioni E, Borch-Johnsen K, et al. Third joint task force of European and other societies on Cardio-vascular Disease Prevention in Clinical Practice. European guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2003; 24: 1601–10.
   Google Scholar
• Omvik P. How smoking affects blood pressure. Blood Press 1996; 5: 71–7.
   PubMedGoogle Scholar
• Lee DH, Ha MH, Kim JR, et al. Effects of smoking cessation on changes in blood pressure and incidence of hypertension: a 4-year follow-up study. Hypertension 2001; 37: 194–8.
   PubMed Web of Science ®Google Scholar
• Green MS, Harari G. A prospective study of effects of changes in smoking habits on blood counts, serum lipids and lipoproteins, body weight and blood pressure in occupa-tionally active men. The Israeli Cordi study. J Cli Epidemiol 1995; 9: 1159–66.
   Google Scholar
• Janzon E, Hedblad B, Berglund G, Engstrom G. Changes in blood pressure and body weight following smoking cessa-tion in women. J Intern Med 2004; 255: 266–72.
   PubMed Web of Science ®Google Scholar
• Primatesta P, Falschetti E, Gupta S, Marmot MG, Poulter NR. Association between smoking and blood pressure. Evidence from the Health Survey for England. Hypertension 2001; 37: 187–93.
   Google Scholar
• US Department of Health and Human Services. Healthy People 2010: Understanding and improving health, 2nd edition. Washington, DC: US Government Printing Office, 2000: 12–22.
   Google Scholar
• Holmen J, editor Hoyt blodtrykk. NSAMs handlingspro-gram. Utredningsrapport nr. U3-1993. Seksjon for helsetje-nesteforskning. Samfunnsmedisinsk forskningssenter. Ver-dal: Statens Institutt for Folkehelse, 1993.
   Google Scholar
• Meland E, Ellekjwr H, Gjelsvik B, Kimsas A, Holmen J, Hetlevik I. Pharmacological prevention of cardiovascular disease in general practice. Tidsskr Nor Lwgeforen 2000; 120: 2643–7.
   PubMedGoogle Scholar
• Petersen H, Nwss A-C, Dalsegg A, et al Behandling av mild hypertensj on. Konsensuskonferanse. Oslo: Norges for-skningsrid. Komiteen for medisinsk teknologivurdering, 1997.
   Google Scholar
• Hetlevik I, Holmen J, Kruger 0, Kristensen P, Iversen H. Implementing clinical guidelines in the treatment of hyper-tension in general practice. Blood Press 1998; 7: 1–7.
   Google Scholar
• MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke and coronary heart disease part I. Prolonged differences in blood pressure: prospective observational studies corrected for regression dilution bias. Lancet 1990; 335: 765–74.
   Google Scholar
• Birkett NJ, Donner AP, Maynard MD. Assessing hyper-tension control in the community: the need for follow-up measurements to ensure clinical relevance. Can Med Assoc J 1987; 136: 595–600.
   Google Scholar
• Furu K, Skurtveit S, Rosvold EO. Drug use questions in Norwegian health surveys - response rate and agreement between specific and open-ended questions. Nor J Epidemiol 2003; 13: 147–54.
   Google Scholar
• Enlund H, Tuomilehto J, Turakka H. Patient report validated against prescription records for measuring use of and compliance with antihypertensive drugs. Acta Med Scand 1981; 209: 271–5.
   Google Scholar
• Klungel OH, de Boer A, Paes AHP, Herings RMC, Seidell JC, Bakker A. Agreement between self-reported antihyper-tensive drug use and pharmacy records in a population-based study in The Netherlands. Pharmacy World & Science 1999; 21: 217–20.
   PubMedGoogle Scholar
• Sogaard AJ, Selmer R, Bjertness E, TheIle D. The Oslo Health Study. The impact of self-selection in a large, population-based survey. Int J Equity Health 2004; 3: 30nline: http://www.equityhealthj.com/content/3/1/3.
   Google Scholar